This Canadian Stock Should Be Avoided Like the Plague Right Now

Here’s why long-term investors may want to simply avoid Cineplex (TSX:CGX) stock like the plague, even if it looks dirt cheap.

| More on:
Caution, careful

Image source: Getty Images

After the record-breaking box office collections of Barbenheimer, investors may think that the Cineplex (TSX:CGX) story may be back on track. But the reality is just the contrary. Even though the company posted growth in its second-quarter (Q2) 2023 quarterly report, it lacks the value that can facilitate long-term returns to investors.

Why? Here are just a few reasons.

Five-year stock price performance of -71%  

At the time of writing, Cineplex stock is down a whopping 71% over the past five years. Notably, this comes despite the stock remaining flat on a year-to-date basis, bolstered by the aforementioned strong box office numbers seen this past quarter.

Despite a return to profitability of late, Cineplex is a company that remains heavily under the microscope of long-term investors. This isn’t the cash flow-producing machine it was five to 10 years ago. Indeed, the cinema business is one with structural headwinds that have continued to manifest themselves in lower customer traffic numbers in recent years.

Competition commissioner sticks to its guns

In late July, Canada’s competition commissioner announced plans to hold its ground on the claim that Cineplex is using deceptive marketing techniques. Responses filed to the tribunal indicated that the Canadian multiplex giant mischaracterized its ticket-purchasing procedures. The claims were essentially that individuals couldn’t book tickets at prices displayed on the website due to additional online booking fees.

While this may be common practice, this is just one of the issues Cineplex is dealing with right now. Consumers have other options (mainly in the form of streaming), and phantom fees and other inconveniences may only serve the company poorly over the long term. Thus, whether Cineplex wins its dispute with the competition commissioner doesn’t really matter — these allegations are indicative of various systemic problems in this sector.

Cineplex’s declining financial health

Cineplex’s financial health took a hit from the pandemic. All investors know that.

However, we’re long past the days of social distancing, mask wearing, and stay-at-home orders. Canadians are able (and for the most part willing) to be jammed back into uncomfortable seating for three hours at a time in an enclosed room.

The thing is, it appears consumers simply don’t want to. Cineplex’s earnings growth rate over the past year was a dismal -16% compared to the entertainment industry, which grew 12.1% over that period. The company’s heavy debt load of $838.4 million remains a thorn in the side of investors, considering its total liabilities ($2.3 billion) are currently greater than its total assets ($2.23 billion).

Bottom line

Cineplex is an intriguing turnaround story for some, with a few interesting catalysts that may entice certain speculators to take a position. However, in my view, long-term investors shouldn’t get sucked into owning this stock here, no matter how cheap it looks.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Chris MacDonald has no position in any of the stocks mentioned. The Motley Fool recommends Cineplex. The Motley Fool has a disclosure policy.

More on Investing

consider the options
Stocks for Beginners

Should Investors Buy goeasy Stock Before Earnings?

Here's what investors should look for before picking up goeasy stock ahead of earnings.

Read more »

growing plant shoots on stacked coins
Stocks for Beginners

Long-Term Investing: 3 Top Canadian Stocks You Can Buy for Under $20 a Share

If you're looking for growth, look for cheap stocks in the right sector. And these three Canadian stocks offer exactly…

Read more »

edit Close-up Of A Piggybank With Eyeglasses And Calculator On Desk
Stocks for Beginners

If You Invested $1,000 in Dollarama Stock 5 Years Ago, This Is How Much You’d Have Now

Dollarama stock (TSX:DOL) has surged in share price in the last five years, but there could be more on the…

Read more »

dividends grow over time
Dividend Stocks

How to Build a Powerful Passive-Income Portfolio With Just $20,000

It is an opportune time to invest $20,000 and boost passive income. Between higher yields and higher dividend growth, which…

Read more »

A bull outlined against a field
Tech Stocks

3 No-Brainer Stocks to Buy Before a Bull Run

Given their healthy growth prospects and attractive valuation, I am bullish on these three stocks ahead of the next bull…

Read more »

healthcare pharma
Tech Stocks

Down 61% From Record Highs, Can Well Health Stock Recover in 2024?

Well Health has crushed broader market returns since its IPO and continues to trade at a discount to consensus price…

Read more »

Shopping card with boxes labelled REITs, ETFs, Bonds, Stocks
Dividend Stocks

How to Build a Bulletproof Monthly Passive-Income Portfolio With Just $7,000 in 2024

You can make passive income without risking your capital. Here's how the CI High Interest Savings ETF (TSX:CSAV) and other…

Read more »

woman retiree on computer
Dividend Stocks

Want $2,000/Year in Passive Income? Invest $26.8K in this Canadian Stock

Make $2,000 per year in passive income through this leading Canadian dividend stock.

Read more »